Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

University of Alberta

$25,000.00

Design of an impedance-based biosensor for colorectal cancer diagnosis

FY 2016-17

Summary
A portable biosensor device, like the ""Tricoder"" in the TV series ""Star Trek"", can be indispensible inperforming rapid chemical and biological testing with versatile applications in healthcare, food safety andenvironmental monitoring. Such tricoder-like biosensing devices will evolve into the Internet-of-things (IoT)and provide point-of-care (POC) services. Recently, they have gained wide research attention worldwide. Theresearch group at the University of Alberta (UofA) led by Dr. Jie Chen has made significant progress in thedesign of impedance-based biosensors over the past years.Colorectal cancer (CRC) is the third most commonly diagnosed cancer globally, after breast and lung cancer.Colonoscopy is the reference standard worldwide for screening patients >50 years old and for monitoring ofpatients with a history of rectal bleeding. However, colonoscopy is an unpleasant experience for patients, andthe procedure is costly. Metabolomic Technologies Inc. (MTI Inc.) is a leading Canadian colorectal cancer(CRC) diagnosis company located in Edmonton, Alberta. The company has developed a metabolite-based urinetest for colorectal cancer diagnosis. Current urine-based clinical tests are quantified using either NuclearMagnetic Resonance spectroscopy (NMR) or Mass Spectrometry (MS). However, NMR or MS is expensiveand not easily accessible, and thus the company is looking for a more cost effective portable POC device toperform CRC tests. The company learned that Dr. Chen at UofA is building an impedance-based POC sensordevice. The proposed activities in this Engagement Grant will focus on designing urine-based colorectal cancertests using such a POC sensor, and comparing the testing accuracy with the NMR or MS-based tests. Bothparties are fully aware that, if any new IP arises from this project, the IP belongs to MTI Inc. This Engagefunding will allow UofA students to learn essential skills needed by the Canadian biotechnology industry.
Program
Engage Grants Program
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
501864-2016
Name nom
Chen, Jie
Department département
Biomedical Engineering
Organization id
9
Institution établissement
University of Alberta
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2016
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1555
Committee name en
Prairie Internal Decision Committee
Committee name fr
Comité de décision interne pour les Prairies
Area of application code
513
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Electrical and electronic machinery and equipment (including computer hardware)
Area of application fr
Machinerie et équipement électriques et électroniques (y compris matériel informatique)
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
1
Nb partie
1
Application title
Design of an impedance-based biosensor for colorectal cancer diagnosis
Keyword
NSERC
Application summary
A portable biosensor device, like the ""Tricoder"" in the TV series ""Star Trek"", can be indispensible inperforming rapid chemical and biological testing with versatile applications in healthcare, food safety andenvironmental monitoring. Such tricoder-like biosensing devices will evolve into the Internet-of-things (IoT)and provide point-of-care (POC) services. Recently, they have gained wide research attention worldwide. Theresearch group at the University of Alberta (UofA) led by Dr. Jie Chen has made significant progress in thedesign of impedance-based biosensors over the past years.Colorectal cancer (CRC) is the third most commonly diagnosed cancer globally, after breast and lung cancer.Colonoscopy is the reference standard worldwide for screening patients >50 years old and for monitoring ofpatients with a history of rectal bleeding. However, colonoscopy is an unpleasant experience for patients, andthe procedure is costly. Metabolomic Technologies Inc. (MTI Inc.) is a leading Canadian colorectal cancer(CRC) diagnosis company located in Edmonton, Alberta. The company has developed a metabolite-based urinetest for colorectal cancer diagnosis. Current urine-based clinical tests are quantified using either NuclearMagnetic Resonance spectroscopy (NMR) or Mass Spectrometry (MS). However, NMR or MS is expensiveand not easily accessible, and thus the company is looking for a more cost effective portable POC device toperform CRC tests. The company learned that Dr. Chen at UofA is building an impedance-based POC sensordevice. The proposed activities in this Engagement Grant will focus on designing urine-based colorectal cancertests using such a POC sensor, and comparing the testing accuracy with the NMR or MS-based tests. Bothparties are fully aware that, if any new IP arises from this project, the IP belongs to MTI Inc. This Engagefunding will allow UofA students to learn essential skills needed by the Canadian biotechnology industry.